Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Faezeh Moakedi"'
Autor:
Samira Jafari, Mehdi Jaymand, Lobat Tayebi, Milad Ghorbani, Zhila Izadi, Faezeh Moakedi, Behrang Shiri Varnamkhasti, Sajad Sarvari, Hossein Derakhshankhah, Ebrahim Barzegari
Publikováno v:
International Journal of Nanomedicine. 15:363-386
The advent of porous materials, in particular zeolitic nanoparticles, has opened up unprecedented putative research avenues in nanomedicine. Zeolites with intracrystal mesopores are low framework density aluminosilicates possessing a regular porous s
Autor:
Nozar Fayaz bakhsh, Kamran Mansouri, Mehdi Jaymand, Zhila Izadi, Hossein Derakhshankhah, Faezeh Moakedi, Hadi Samadian, Jan Janczak, Vali Ollah Kashani, Mohammad Jaafar Soltanian Fard, Payam Hayati, Foad Noori, Samira Jafari, Loghman Alaei
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports
Scientific Reports
This scenario was designed to investigate the protein corona pattern on the pillar-layer surface of a Cu-based metal–organic framework (MOF) in human plasma. The [Cu(L)(L/)].1.3DMA (MOF-1) {L = 4, 4/-bipyridine and L/ = 5-aminoisophthalic acid}, wa
Autor:
Massoud Amanlou, Shabnam Mahernia, Gianluca Fossati, Malihe Hassanzadeh, Faezeh Moakedi, Mehdi Adib, Gianluca Caprini
Designing dual small molecule inhibitors against enzymes associated with cancer has turned into a new strategy in cancer chemotherapy. Targeting DNA methyltransferase (DNMT) and histone deacetylase (HDAC) enzymes, involved in epigenetic modifications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590d290597a046ff9327aadf4e0a906a
Autor:
Hossein Derakhshankhah, Willis Collins Akeyo Muganda, Mareike Müller, Zhila Izadi, Mohammad Raoufi, Samira Jafari, John F. Presley, Sajad Sarvari, Mojtaba Falahati, Faezeh Moakedi, Majid Sharifi, Soraya Sajadimajd
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine. 24
Alzheimer's disease (AD) is a multifactorial neurodegenerative disease which leads to progressive dysfunction of cognition, memory and learning in elderly people. Common therapeutic agents are not only inadequate to suppress the progression of AD pat